Expression of ephrin receptor A3 in glandular epithelial cells of uterine endometrium in patients with endometriosis and endometrial cancer
- 作者: Chuprynin V.D.1, Muftaydinova S.K.1, Senina D.N.1, Fayzullina N.M.1, Asaturova A.V.1, Buralkina N.A.1, Fayzullin L.Z.1, Ovodenko D.L.1, Kozachenko A.V.1
-
隶属关系:
- Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
- 期: 编号 6 (2022)
- 页面: 98-104
- 栏目: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/249560
- DOI: https://doi.org/10.18565/aig.2022.6.98-104
- ID: 249560
如何引用文章
详细
全文:
作者简介
Vladimir Chuprynin
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: v_chuprynin@oparina4.ru
PhD, Head of the Surgical Department
Shakhnoza Muftaydinova
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russiagraduate student
Daria Senina
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: n_buralkina@oparina4.ru
graduate student
Nafisa Fayzullina
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of RussiaPh.D., Senior Researcher at the 1st Pathology Department
Alexandra Asaturova
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: a_asaturova@oparina4.ru
Dr. Med. Sci., Head of the 1st Pathology Department
Natalya Buralkina
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: n_buralkina@oparina4.ru
Dr. Med. Sci., Senior Researcher at Surgical Department
Leonid Fayzullin
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: l_faizullin@oparina4.ru
PhD, Leading Researcher at the Laboratory of Molecular Genetic Methods
Dmitry Ovodenko
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: d_ovodenko@oparina4.ru
Dr. Med. Sci., Head of the Department of Clinical Work, Oncologist at the Department of Innovative Oncology and Gynecology
Andrey Kozachenko
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: a_kozachenko@oparina4.ru
Dr. Med. Sci., Leading Researcher
参考
- Лисовская Е.В., Хилькевич Е.Г., Чупрынин В.Д., Мельников М.В., Ипатова М.В. Качество жизни женщин с глубоким инфильтративным эндометриозом. Акушерство и гинекология. 2020; 3: 116-26. https://dx.doi.org/10.18565/aig.2020.3.116-126.
- Bulun S.E., Yilmaz B.D., Sison C., Miyazaki K., Bernardi L., Liu S. et al. Endometriosis. Endocr. Rev. 2019; 40(4): 1048-79. https://dx.doi.org/10.1210/er.2018-00242.
- Адамян Л.В., Мартиросян Я.О., Асатурова А.В. Этиопатогенез эндометриоз-ассоциированного бесплодия (обзор литературы). Проблемы репродукции. 2018; 24(2): 28-33. https://doi.org/10.17116/repro201824228-33.
- Адамян Л.В., Андреева Е.Н., Беженарь В.Ф. Эндометриоз: диагностика, лечение и реабилитация. Клинические рекомендации по ведению больных. М.; 2013. 58с.
- Kajiyama H., Suzuki S., Yoshihara M., Tamauchi S., Yoshikawa N., Niimi K. et al. Endometriosis and cancer. Free Radic. Biol. Med. 2019; 133: 186-92. https://dx.doi.org/10.1016/j.freeradbiomed.2018.12.015.
- Щеголев А.И., Быков А.Г., Туманова У.Н., Павлович С.В. Эндометриоз и развитие опухолей. Акушерство и гинекология. 2016; 11: 49-56. [Shchegolev A.I., Bykov A.G., Tumanova U.N., Pavlovich S.V. Endometriosis and the development of tumors. Obstetrics and Gynecology. 2016; 11: 49-56. (in Russian)]. https://dx.doi.org/10.18565/aig.2016.11.49-56.
- Lodola A., Giorgio C., Incerti M., Zanotti I., Tognolini M. Targeting Eph/ephrin system in cancer therapy. Eur. J. Med. Chem. 2017; 142: 152-62. https://dx.doi.org/10.1016/j.ejmech.2017.07.029.
- Kaczmarek R., Zimmer K., Gajdzis P., Gajdzis M. The role of eph receptors and ephrins in corneal physiology and diseases. Int. J. Mol. Sci. 2021; 22(9): 4567. https://dx.doi.org/10.3390/ijms22094567.
- Pitulescu M.E., Adams R.H. Eph/ephrin molecules--a hub for signaling and endocytosis. Genes Dev. 2010; 24(22): 2480-92. https://dx.doi.org/10.1101/gad.1973910.
- Kania A., Klein R. Mechanisms of ephrin-Eph signalling in development, physiology and disease. Nat. Rev. Mol. Cell Biol. 2016; 17(4): 240-56. https://dx.doi.org/10.1038/nrm.2015.16.
- Tang F.H.F., Davis D., Arap W., Pasqualini R., Staquicini F.I. Eph receptors as cancer targets for antibody-based therapy. Adv. Cancer Res. 2020; 147: 303-17. https://dx.doi.org/10.1016/bs.acr.2020.04.007.
- Janes P.W., Slape C.I., Farnsworth R.H., Atapattu L., Scott A.M., Vail M.E. EphA3 biology and cancer. Growth Factors. 2014; 32(6): 176-89.https://dx.doi.org/10.3109/08977194.2014.982276.
- To C., Farnsworth R.H., Vail M.E., Chheang C., Gargett C.E., Murone C. et al. Hypoxia-controlled EphA3 marks a human endometrium-derived multipotent mesenchymal stromal cell that supports vascular growth. PLoS One. 2014; 9(11): e112106. https://dx.doi.org/10.1371/journal.pone.0112106.
- Lessey B.A., Young S.L. What exactly is endometrial receptivity? Fertil. Steril. 2019; 111(4): 611-7. https://dx.doi.org/10.1016/j.fertnstert.2019.02.009.
- Chen X., Lu B., Ma Q., Ji C.D., Li J.Z. EphA3 inhibits migration and invasion of esophageal cancer cells by activating the mesenchymalepithelial transition process. Int. J. Oncol. 2019; 54(2): 722-32. https://dx.doi.org/10.3892/ijo.2018.4639.
- La Rocca F., Airoldi I., Di Carlo E., Marotta P., Falco G., Simeon V. et al. EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells. Cell. Oncol. (Dordr.). 2017; 40(5): 48396. https://dx.doi.org/10.1007/s13402-017-0338-4.
- London M., Gallo E. Critical role of EphA3 in cancer and current state of EphA3 drug therapeutics. Mol. Biol. Rep. 2020; 47(7): 5523-33. https://dx.doi.org/10.1007/s11033-020-05571-8.
- Lahtela J., Pradhan B., Narhi K., Hemmes A., Sarkioja M., Kovanen P.E. et al. The putative tumor suppressor gene EphA3 fails to demonstrate a crucial role in murine lung tumorigenesis or morphogenesis. Dis. Models Mech. 2015; 8(4): 393-401. https://dx.doi.org/10.1242/dmm.019257.
- Andretta E., Carton-Garcia F., Martinez-Barriocanal A., de Marcondes P.G., Jimenez-Flores L.M., Macaya I. et al. Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer. Sci. Rep. 2017; 7: 41576. https://dx.doi.org/10.1038/srep41576.
- Wang X., Xu H., Cao G., Wu Z., Wang J. Loss of EphA3 protein expression is associated with advanced TNM stage in clear-cell renal cell carcinoma. Clin. Genitourin. Cancer. 2017; 15(2): e169-73. https://dx.doi.org/10.1016/j.clgc.2016.07.028.
- Vecchi M., Confalonieri S., Nuciforo P., Vigano M.A., Capra M., Bianchi M. et al. Breast cancer metastases are molecularly distinct from their primary tumors. Oncogene. 2008; 27(15): 2148-58. https://dx.doi.org/10.1038/sj.onc.1210858.